3 research outputs found
Characteristics of patients included in the cohort, with a detail of those responding and those not responding to ELISPOT PHA positive control.
*<p><i>p</i> value for difference between PHA<100 and PHA≥100 SFC/10<sup>6</sup>.</p
Distribution of responses to PHA and ESAT6/CFP10 ELISPOT assays in HIV patients, by CD4 cell count (boxplot showing median, IQR and range) (n = 285).
<p>1A: Distribution of responses to PHA. 1B: Distribution of responses to ESAT6/CFP10.</p
Analysis of the determinants of positive response to the ESAT6/CFP10 ELISPOT assay and to the TST (n = 247).
<p>Analysis of the determinants of positive response to the ESAT6/CFP10 ELISPOT assay and to the TST (n = 247).</p